Silence Therapeutics
AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal
March 25, 2020Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma
Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …
Silence Therapeutics appoints ex-Akari CEO in top position
July 17, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand
Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …
Silence Therapeutics instate new COO
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics
Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Silence Therapeutics appoints chief medical adviser
September 19, 2012Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics
Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …
AstraZeneca extends siRNA collaboration
July 14, 2010Research and Development AstraZeneca, RNA, Silence Therapeutics
AstraZeneca has agreed a one-year extension on its siRNA development collaboration with London-based Silence Therapeutics. Silence is a specialist in …
Silence Therapeutics promotes Jorg Kaufmann
May 21, 2010Research and Development Silence Therapeutics, appointment, research and development, rnai
Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …
